Publikace
- Pharmacoeconomic Impact of Different Regimens to Prevent Cytomegalovirus Infection in Renal Transplant Recipients2012 | 1. lékařská fakulta, Lékařská fakulta v Plzni
- Long-Term Outcomes of Pre-emptive Valganciclovir Compared with Valacyclovir Prophylaxis for Prevention of Cytomegalovirus in Renal Transplantation2012 | 1. lékařská fakulta, Lékařská fakulta v Plzni
- Valganciclovir prophylaxis against cytomegalovirus impairs lymphocyte proliferation and activation in renal transplant recipients2011 | 1. lékařská fakulta, Lékařská fakulta v Plzni
- Intragraft cytomegalovirus infection: results of randomized trial of valacyclovir prophylaxis vs. preemptive valganciclovir therapy in renal transplant recipients2010 | Ústřední knihovna
- Effect of cytomegalovirus viremia on subclinical rejection or interstitial fibrosis and tubular atrophy in protocol biopsy at 3 months in renal allograft recipients managed by preemptive therapy or antiviral prophylaxis2009 | Ústřední knihovna
- Role virů v patogenezi rejekce štěpu2007 | Ústřední knihovna
- Prospective comparison of valacyclovir and oral ganciclovir for prevention of cytomegalovirus disease in high-risk renal transplant recipients2005 | Lékařská fakulta v Plzni, Ústřední knihovna
- Plasma and tissue levels of free oxygen radicals in recipients of kidneys from non-heart-beating donors: does recipient pretreatment with antioxidant drugs make sense? An experimental study in pigs2002 | Lékařská fakulta v Plzni, Ústřední knihovna
- A Randomized Trial of Valganciclovir Prophylaxis Versus Preemptive Therapy in Kidney Transplant Recipients2023 | Lékařská fakulta v Plzni
- Safety and efficacy of one and two booster doses of SARS-CoV-2 mRNA vaccines in kidney transplant recipients: A randomized clinical trial2023 | Lékařská fakulta v Plzni
Loading network view...